New stent aims to seal brain aneurysms safely

NCT ID NCT05543447

Recruiting now Disease control Sponsor: Acandis GmbH Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a device called DERIVO 2heal, a small mesh tube placed in an artery to block blood flow into a brain aneurysm. The goal is to see if it safely and effectively seals the aneurysm over the medium and long term. About 158 adults with brain aneurysms will be enrolled, and researchers will track outcomes like complete aneurysm closure and any strokes or complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DERIVO 2heal Embolisation Device (a flow-diverting stent placed in the artery to block blood flow to the aneurysm)
What this could lead to: If successful, this device could offer a safer, more effective way to treat brain aneurysms and reduce the risk of rupture or stroke.
What could go wrong: This is a mid-stage study with 158 participants, so results may not apply to everyone. Risks include stroke, bleeding, or device-related complications like blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FLOW DIVERTER INTRACRANIAL ANEURYSM

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Charité - Universitätsmedizin Berlin
RECRUITING

Berlin, Germany
Klinikum Bremerhaven-Reinkenheide
RECRUITING

Bremerhaven, Germany
Klinikum Vest - Knappschaftskrankenhaus Recklinghausen
RECRUITING

Recklinghausen, Germany
Krankenhaus Nordwest Frankfurt
RECRUITING

Frankfurt am Main, Germany
Ludwig-Maximilians-Universität München
RECRUITING

München, Germany
Mühlenkreiskliniken | Johannes Wesling Klinikum Minden
RECRUITING

Minden, Germany
Städtisches Klinikum Solingen
RECRUITING

Solingen, Germany
Technische Universität München
RECRUITING

München, Germany
Universitätsklinikum Augsburg
RECRUITING

Augsburg, Germany
Universitätsklinikum Carl Gustav Carus Dresden
RECRUITING

Dresden, Germany
Universitätsklinikum Düsseldorf
RECRUITING

Düsseldorf, Germany
Universitätsklinikum Essen
RECRUITING

Essen, Germany
Universitätsklinikum Hamburg-Eppendorf
RECRUITING

Hamburg, Germany
Universitätsklinikum Köln
RECRUITING

Cologne, Germany
Universitätsklinikum Magdeburg
RECRUITING

Magdeburg, Germany
Universitätsmedizin Halle
RECRUITING

Halle, Germany
Westpfalz-Klinikum Kaiserslautern
RECRUITING

Kaiserslautern, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.